Fakta om udbudet
EU-nr
2015/S 094-169777
Offentliggjort
18.05.2015
Udbudstype
Andre
Udbyder
University of Copenhagen
Vindere
Winner:
(18.05.2015)
BD Biosciences
Herstedøstervej 27-29 Bygning A, 2. Sal
2620 Albertslund
Acquisition of a FACS Aria I to Institut for Cellulær og Molekylær Medicin
University of Copenhagen
Voluntary ex ante transparency notice
This notice is covered by: Directive 2004/18/EC
Section I: Contracting authority/entity
I.1) Name, addresses and contact point(s)
University of Copenhagen
Nørregade 10
For the attention of: Line Kolle
1017 København K
DENMARK
Telephone: +45 35334470
E-mail: line.kolle@adm.ku.dk
Internet address(es):
General address of the contracting authority/entity: www.indkoeb.ku.dk
I.2) Type of the contracting authority
Body governed by public law
I.3) Main activity
Other: University
1.4) Contract award on behalf of other contracting authorities/entities
The contracting authority/entity is purchasing on behalf of other contracting authorities/entities: no
Section II: Object of the contract
II.1) Description
II.1.1) Title attributed to the contract
Acquisition of a FACS Aria I to Institut for Cellulær og Molekylær Medicin.
II.1.2) Type of contract and location of works, place of delivery or of performance
Supplies
Purchase
Purchase
NUTS code DK011
II.1.3) Information about a framework agreement or a dynamic purchasing system (DPS)
II.1.4) Short description of the contract or purchase(s)
The procurement involves the purchase of a new cell sorter, FACS Fusion, from BD Bioscience as well as a complete system upgrade of our current sorter, FACS Aria I to the level of a FACS Aria II. The demand of cell sorters at our labs has increased immensely after joining of Stephen Cohen's group to ICMM, which cannot be solely met by our current sorter. The FACS Aria cell sorter is one of the fundamental equipment used in our laboratory for different research projects and it runs on a daily basis.
II.1.5) Common procurement vocabulary (CPV)
38000000
II.6) Information about Government Procurement Agreement (GPA)
The contract is covered by the Government Procurement Agreement (GPA): yes
II.2) Total final value of contract(s)
II.2.1) Total final value of contract(s)
Value: 4 017 505 DKK
Excluding VAT
Excluding VAT
Section IV: Procedure
IV.1) Type of procedure
Award of a contract without prior publication of a contract notice in the Official Journal of the European Union (in the cases listed in Section 2 of Annexes D1, D2 or D3 as appropriate)
Justification for the choice of the negotiated procedure without prior publication of a contract notice in the OJEU in accordance with Directive 2004/18/EC
No tenders or no suitable tenders in response to: open procedure
The products involved are manufactured purely for the purpose of research, experiment, study or development under the conditions stated in the Directive: yes
The works/goods/services can be provided only by a particular tenderer for reasons that are: technical
Other justification for the award of the contract without prior publication of a contract notice in the OJEU
The contract falls outside the scope of application of the Directive
According to the European Parliament and Council Directive No. 2004/18 / EC, Article 31. 1, point b, the University of Copenhagen believes that only BD Biosciences can perform an upgrade of our current instrument. Having two functionally identical sorters, will allow us to utilize the exact same protocol for analysis and sorting when preparing samples. This will allow for maximal flexibility, when setting up experiments. Future data and data generated during the last 10 years can readily be compared, as the software and hardware parameters essentially are identical. Software and day-to-day maintenance of the two instruments will be similar, simplifying all procedures for the users. We are getting a significant discount on upgrading our existing instrument under this contract. By having two similar machines from the same supplier a number of advantages are achieved besides technical and functional ones. The two machines will share a number of consumables and spare parts simplifying all maintenance. BD Bioscience will be responsible for all service of the machines, giving us a discount when negotiating service contracts. Training of new users will be simplified greatly if they can be introduced to one type of instrument and one type of software. According to the European Parliament and Council Directive No. 2004/18 / EC, Article 31. 2, point b, University of Copenhagen is convinced that all analyses performed the last decade on our current FACS Aria I are most relevantly compared with the same or similar machine. Only BD Bioscience can upgrade our current FACS Aria I with appropriate spare parts. No other supplier can provide this.
Justification for the choice of the negotiated procedure without prior publication of a contract notice in the OJEU in accordance with Directive 2004/18/EC
No tenders or no suitable tenders in response to: open procedure
The products involved are manufactured purely for the purpose of research, experiment, study or development under the conditions stated in the Directive: yes
The works/goods/services can be provided only by a particular tenderer for reasons that are: technical
Other justification for the award of the contract without prior publication of a contract notice in the OJEU
The contract falls outside the scope of application of the Directive
According to the European Parliament and Council Directive No. 2004/18 / EC, Article 31. 1, point b, the University of Copenhagen believes that only BD Biosciences can perform an upgrade of our current instrument. Having two functionally identical sorters, will allow us to utilize the exact same protocol for analysis and sorting when preparing samples. This will allow for maximal flexibility, when setting up experiments. Future data and data generated during the last 10 years can readily be compared, as the software and hardware parameters essentially are identical. Software and day-to-day maintenance of the two instruments will be similar, simplifying all procedures for the users. We are getting a significant discount on upgrading our existing instrument under this contract. By having two similar machines from the same supplier a number of advantages are achieved besides technical and functional ones. The two machines will share a number of consumables and spare parts simplifying all maintenance. BD Bioscience will be responsible for all service of the machines, giving us a discount when negotiating service contracts. Training of new users will be simplified greatly if they can be introduced to one type of instrument and one type of software. According to the European Parliament and Council Directive No. 2004/18 / EC, Article 31. 2, point b, University of Copenhagen is convinced that all analyses performed the last decade on our current FACS Aria I are most relevantly compared with the same or similar machine. Only BD Bioscience can upgrade our current FACS Aria I with appropriate spare parts. No other supplier can provide this.
IV.2) Award criteria
IV.2.1) Award criteria
IV.2.2) Information about electronic auction
An electronic auction will be used: no
IV.3) Administrative information
IV.3.1) File reference number attributed by the contracting authority/entity
043-0142/15-7000
IV.3.2) Previous publication(s) concerning the same contract
no
Section V: Award of contract
V.1) Date of contract award decision:
V.2) Information about offers
V.3) Name and address of economic operator in favour of whom the contract award decision has been taken
BD Biosciences
Herstedøstervej 27-29 Bygning A, 2. Sal
2620 Albertslund
DENMARK
Telephone: +45 43434566
Fax: +45 43434166
V.4) Information on value of contract
Initial estimated total value of the contract:
Value: 4 017 505 EUR
Excluding VAT
Total final value of the contract:
Value: 4 017 505 EUR
Excluding VAT
Value: 4 017 505 EUR
Excluding VAT
Total final value of the contract:
Value: 4 017 505 EUR
Excluding VAT
V.5) Information about subcontracting
The contract is likely to be sub-contracted: no
Section VI: Complementary information
VI.1) Information about European Union funds
The contract is related to a project and/or programme financed by European Union funds: no
VI.2) Additional information:
The focus of the department is the functional cell, its genetic components and molecular cellular mechanisms in a medical context. With a firm foundation in the basic function of the normal and differentiating cell an understanding of the molecular, cellular and genetic mechanisms behind disease and aging is sought. The aim of the department is to exploit new discoveries and mechanistic insight as guidelines for translational medicine in terms of novel principles for treatment and diagnosis of disease in an internationally competitive, inspiring, productive scientific environment exploiting state of the art (and beyond) methodology.
VI.3) Procedures for appeal
VI.3.1) Body responsible for appeal procedures
Klagenævnet for udbud
Dahlerups Pakhus, Langelinie Allé 17
2100 København Ø
DENMARK
E-mail: klfu@erst.dk
Telephone: +45 35291000
Internet address: http://www.klfu.dk
VI.3.2) Lodging of appeals
Precise information on deadline(s) for lodging appeals A complaint against the contracting entity who, in accordance with the European Parliament and Council Directive No. 2004/18/EC, Article 31, has decided to award a contract without prior publication of a contract notice in the Official Journal of the European Union must,in accordance with the Danish act on enforcement of procurement rules, etc. § 7, para. 3, be filed to the Danish Public procurement Appeal Board within 30 calendar days from the day following the day on which a contract notice is published in the Official Journal of the European Union.
The Danish act on enforcement of procurement rules, etc. defines in § 3, para. 1, point 1, a standstill period of 10 calendar days from the day after the date on which the voluntary ex ante transparency notice is published in the Official Journal of the European Union.
Latest at the same time as a complaint is lodged to the Danish Public procurement Appeal Board, the appellant shall in writing inform the contracting entity about the lodging of a complaint to the Danish Public procurement Appeal Board, and whether the complaint has been submitted in the stand still period. In cases where the complaint is not submitted in the stand still period, the appellant must specify any suspensive effect of the complaint according to The Danish act on enforcement of procurement rules § 12, Para. 1.
The Danish act on enforcement of procurement rules, etc. defines in § 3, para. 1, point 1, a standstill period of 10 calendar days from the day after the date on which the voluntary ex ante transparency notice is published in the Official Journal of the European Union.
Latest at the same time as a complaint is lodged to the Danish Public procurement Appeal Board, the appellant shall in writing inform the contracting entity about the lodging of a complaint to the Danish Public procurement Appeal Board, and whether the complaint has been submitted in the stand still period. In cases where the complaint is not submitted in the stand still period, the appellant must specify any suspensive effect of the complaint according to The Danish act on enforcement of procurement rules § 12, Para. 1.
VI.3.3) Service from which information about the lodging of appeals may be obtained
Konkurrence- og Forbrugerstyrelsen
Carl Jacobsens Vej 35, København
2500 Valby
DENMARK
E-mail: kfst@kfst.dk
Telephone: +45 41715000
Internet address: http://www.kfst.dk
VI.4) Date of dispatch of this notice:
12.5.2015